Bioabsorbable Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Bioabsorbable Heart Stent Market Demand and it is segmented by Product Type (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Application (Coronary Artery Disease, Peripheral Artery Disease) Absorption Rate (Slow absorption Rate, Fast absorption Rate), End User (Hospital and Other end User), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Bioabsorbable Stents Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Bioabsorbable Stents Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.08 Billion
Market Size (2029) USD 1.63 Billion
CAGR (2024 - 2029) 8.76 %
Fastest Growing Market North America
Largest Market Europe

Major Players

Bioabsorbable Stents Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Bioabsorbable Stents Market Analysis

The Global Bioabsorbable Stents Market size is estimated at USD 1.08 billion in 2024, and is expected to reach USD 1.63 billion by 2029, growing at a CAGR of 8.76% during the forecast period (2024-2029).

The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on health care and cardiac surgery. As per the Society of Thoracic Surgeons (STS) database in February 2021, Cardiac surgery volumes in the United States fell by more than half during the COVID-19 pandemic's first wave, with the biggest drops observed in the New England and mid-Atlantic regions. Other studies that looked at the early weeks and months of COVID-19 found that when hospitals' services were shut down or severely limited and patients were hesitant to seek help there were widespread cardiac effects such as missed ST-segment elevation myocardial infarction (STEMIs), higher rates of cardiac arrest, and fewer diagnostic and elective procedures. Thus, the decline in the cardiac surgery volume significantly impacted the market growth.

Factors that are driving the market include a high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population. For instance, according to a World Health Organization article published July 2021, an estimated 17.9 million people worldwide die from heart disease each year. This represents 31% of deaths worldwide, and 85% of these deaths are mainly caused by heart disease and stroke. This high prevalence of cardiovascular diseases and deaths associated to it are expected to drive demand for early diagnosis and treatment, which will expand the scope of the market studied and boost its market growth over the forecast period.

Furthermore rise in geriatric population who are more prone towards the chronic diseases such as heart diseases anticipated to boost the market demand. According to the World Health Organization Facts of October 2021, the proportion of the global population aged 60 and up will nearly double from 12% to 22% between 2015 and 2050. By 2050, 80% of the world's elderly will live in low- and middle-income countries. The population is ageing at a much faster rate than in the past. Every country faces significant challenges in ensuring that its health and social systems are prepared to take advantage of this demographic shift.

In addition, growing base of obese population bolster the bioabsorbable stent demand boost the market growth over the forecast period. According to the World Health Organization's report published in June 2021, 39 million children under the age of 5 years were overweight or obese in 2020. Incidences of obesity have been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Thus, increasing in the prevalence of obesity makes patients more prone towards the heart diseases thereby expected to boosting the market growth.

However, growing product launches by the key market players anticipated to boost the market growth. For Instance, in December 2021, Svelte Medical Systems received United States Food and Drug Administration (FDA) approval to commercialize the SLENDER IDS fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems for the treatment of coronary artery disease in the United States.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period. However, stringent regulatory scenario, high cost of devices as well as safety issues restraint the market over the forecast period.

Bioabsorbable Stents Market Trends

This section covers the major market trends shaping the Bioabsorbable Stents Market according to our research experts:

Polymer-based Bioabsorbable Stents Sub-segment is Expected to hold its High Market Share in the Product Type Segment

The Bioresorbable Polymer-Based Stents segment is expected to dominate the other segment of the market. The factors can be attributed to the increasing number of approvals for polymer-based stents in different regions, as well as the increased focus on developing polymeric stents.

Bioabsorbable stents (BAS)/polymer-based bioabsorbable stents are made of materials that can completely dissolve or be absorbed in the body. These are used both in peripheral and coronary artery disease. Most bioabsorbable stents are made of polylactic acid, a naturally dissolvable material. However, the polymer materials, such as polycarbonates, polyesters, corrodible metals, and bacterial-derived polymers are under investigation for developing the next-generation bioabsorbable stents.

According to the study titled "Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY" published in the Catheterization and Cardiovascular Intervention in May 2020, In high-risk patients undergoing percutaneous coronary intervention (PCI), the safety and efficacy of bioabsorbable polymer (BP) drug-eluting stents (DES) remain superior to durable polymer (DP) DES. Thus, high safety and efficacy of the polymerbased bioabsorbable stent anticipated to boost the segment growth over the forecast period.

However, key market players focused on the launch of the new polymer-based bioabsorbable stent in the market. For instance, in September 2021, Biotronik reported that its Orsiro Mission bioabsorbable polymer coronary drug-eluting stent system has been approved by the Food and Drug Administration. The device's first implantation and full commercial availability in the United States were also reported by the company. The Orsiro Mission BP-DES received European CE Mark approval in February 2020, according to the company.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period.

Bioabsorbable Stents Market: Research Funding for Coronary Heart Diseases (in Million), United States, 2019-2021

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America currently dominates the market for bioabsorbable stents and is expected to continue its stronghold for a few more years. North America holds the largest market share for bioabsorbable stents due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as a good reimbursement scenario, have been driving the North American bioabsorbable stent market.

According to the American Heart Association, in 2019, approximately 121.5 million United States adults had some form of cardiovascular disease. Also, according to the Centers for Disease Control and Prevention, 2019, approximately 18.2 million United States adults have coronary artery disease, and 805,000 Americans have a heart attack each year. The increasing patient pool is boosting the market growth in the region.

Furthermore, the availability of technologically advanced products in the United States also drives the market growth. For instance, in April 2021,BIOTRONIK received Health Canada approval of the Orsiro drug-eluting stent (DES) system. It is the first and only ultrathin strut DES to outperform the former clinical standard, Xience DES1. Orsiro has been used to treat almost three million patients worldwide to date. Also, as per the news published by Diagnostics and Interventional Cardiologist (DIAC) in April 2019, more than 800,000 percutaneous coronary intervention (PCI) procedures are performed annually in the United States and fewer than 8,000 require a covered stent. Hence, the need for stents is likely to drive the growth in the United States.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period.

Bioabsorbable Stents Market- Growth Rate By Region

Bioabsorbable Stents Industry Overview

The bioabsorbable stents market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at affordable prices. Companies, like Boston Scientific Corporation, Arterius Limited, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd, and Terumo Corporation, hold the substantial share in the market.

Bioabsorbable Stents Market Leaders

  1. Boston Scientific Corporation

  2. Arterius Limited

  3. Kyoto Medical Planning Co. Ltd

  4. Terumo Corporation

  5. Elixir Medical Corporation

*Disclaimer: Major Players sorted in no particular order

Bioabsorbable Stents Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Bioabsorbable Stents Market News

  • In March 2022, Medical devices firm S3V Vascular Technologies has decided to establish a INR 250 crore stent manufacturing facility at the Telangana Medical Devices Park, near Hyderabad.
  • In February 2022, The Ultrathin Strut Orsiro Coronary Drug-Eluting Stent (DES) by BIOTRONIK sets a new clinical benchmark. The final 5-year data from the BIOFLOW-V trial confirms Orsiro DES' superior safety, reaffirming Orsiro's status as the clinical benchmark for DES.

Bioabsorbable Stents Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Introduction to Market Drivers and Restraints

    3. 4.3 Market Drivers

      1. 4.3.1 High Prevalence of Cardiovascular Diseases Globally

      2. 4.3.2 Steep Increase in Aging Population

      3. 4.3.3 Expanding Base of Obese Population

    4. 4.4 Market Restraints

      1. 4.4.1 Stringent Regulatory Scenario

      2. 4.4.2 High Device Cost

      3. 4.4.3 Safety Issues Related to Bioabsorbable Stents

    5. 4.5 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.5.1 Threat of New Entrants

      2. 4.5.2 Bargaining Power of Buyers/Consumers

      3. 4.5.3 Bargaining Power of Suppliers

      4. 4.5.4 Threat of Substitute Products

      5. 4.5.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Product

      1. 5.1.1 Polymer-based Bioabsorbable Stents

      2. 5.1.2 Metal-based Bioabsorbable Stents

    2. 5.2 By Application

      1. 5.2.1 Coronary Artery Disease

      2. 5.2.2 Peripheral Artery Disease

    3. 5.3 By Absorption Rate

      1. 5.3.1 Slow Absorption Rate

      2. 5.3.2 Fast Absorption Rate

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Arterius Limited

      3. 6.1.3 Elixir Medical Corporation

      4. 6.1.4 Kyoto Medical Planning Co. Ltd

      5. 6.1.5 Terumo Corporation

      6. 6.1.6 Abbott Laboratories Inc.

      7. 6.1.7 Amaranth Medical

      8. 6.1.8 Biotronik

      9. 6.1.9 Meril Life Sciences Pvt. Ltd

      10. 6.1.10 Reva Medical

      11. 6.1.11 Svelte Medical Systems

      12. 6.1.12 Lepu Medical Technology Co. LTD

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Bioabsorbable Stents Industry Segmentation

As per the scope of the report, in medicine, a stent is any device that is inserted into a blood vessel or other internal duct to expand it to prevent or alleviate a blockage. Traditionally, such devices are fabricated from metal mesh and remain in the body permanently or until removed through further surgical intervention. Bioresorbable stent (BRS) devices are coronary stents that can fully dissolve in the body. The Bioabsorbable Stents Market is segmented by Product Type (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Application (Coronary Artery Disease, Peripheral Artery Disease) Absorption Rate (Slow absorption Rate, Fast absorption Rate), End User (Hospital and Other end User), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
By Application
Coronary Artery Disease
Peripheral Artery Disease
By Absorption Rate
Slow Absorption Rate
Fast Absorption Rate
By End User
Hospitals
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Bioabsorbable Stents Market Research FAQs

The Global Bioabsorbable Stents Market size is expected to reach USD 1.08 billion in 2024 and grow at a CAGR of 8.76% to reach USD 1.63 billion by 2029.

In 2024, the Global Bioabsorbable Stents Market size is expected to reach USD 1.08 billion.

Boston Scientific Corporation, Arterius Limited, Kyoto Medical Planning Co. Ltd, Terumo Corporation and Elixir Medical Corporation are the major companies operating in the Global Bioabsorbable Stents Market.

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the Europe accounts for the largest market share in Global Bioabsorbable Stents Market.

In 2023, the Global Bioabsorbable Stents Market size was estimated at USD 0.99 billion. The report covers the Global Bioabsorbable Stents Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Bioabsorbable Stents Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Bioabsorbable Stents Industry Report

Statistics for the 2024 Bioabsorbable Stents market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bioabsorbable Stents analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Bioabsorbable Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)